Thimble Point Acquisition Corp.
THMA
NASDAQ9.30
USD
+0.18
- -
Thimble Point Acquisition Corp.
THMA
(NASDAQ)
Recent
price
9.30
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Thimble Point Acquisition Corp. (THMA) is a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It has not identified any specific target company or industry sector for its initial business combination as of the latest available information. The company does not currently generate revenue from operations and its activities primarily involve seeking and completing a de-SPAC transaction; it offers no products or services beyond its SPAC structure, which includes units consisting of common stock and warrants traded on Nasdaq. Thimble Point Acquisition Corp. was founded in 2024 and is headquartered in New York, New York; it operates principally in the United States with no disclosed international geographic footprint or subsidiaries. No recent partnerships, strategic alliances, funding rounds beyond its initial public offering, acquisitions, new product launches, major strategic shifts, name changes, or significant operational changes have been publicly announced for the company in the last 1-2 years.
Chamath Palihapitiya Announces SPAC Deal For Akili: Revolutionary Digital Therapy For Mental Illness
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Thimble Point Acquisition Corp. with Pear Therapeutics, Inc.
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Thimble Point Acquisition Corp. for Potential Breaches of Fiduciary Duty By Its Board of Directors
Digital Therapy Company Going Public Via SPAC Merger